SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aster DM Healthcare gains on reporting consolidated net profit of Rs 44 crore in Q1

12 Aug 2021 Evaluate

Aster DM Healthcare is currently trading at Rs. 157.80, up by 1.00 points or 0.64% from its previous closing of Rs. 156.80 on the BSE.

The scrip opened at Rs. 156.00 and has touched a high and low of Rs. 158.85 and Rs. 150.80 respectively. So far 34323 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 179.90 on 20-Nov-2020 and a 52 week low of Rs. 120.00 on 10-Sep-2020.

Last one week high and low of the scrip stood at Rs. 168.45 and Rs. 148.70 respectively. The current market cap of the company is Rs. 7754.94 crore.

The promoters holding in the company stood at 37.88%, while Institutions and Non-Institutions held 18.33% and 43.79% respectively.

Aster DM Healthcare has reported net loss at Rs 7.42 crore for the quarter ended June 30, 2021 as compared to net loss of Rs 27.52 crore for the same quarter in the previous year. However, total income of the company increased by 91.67% at Rs 259.52 crore for Q1FY22 as compared Rs 135.40 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported net profit attributable to owners at Rs 44.47 crore for the quarter ended June 30, 2021 as compared to net loss of Rs 82.93 crore for the same quarter in the previous year. Total income of the company increased by 35.69% at Rs 2379.63 crore for Q1FY22 as compared Rs 1753.69 crore for the corresponding quarter previous year.

Aster DM Healthcare Share Price

688.30 13.15 (1.95%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×